BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17888614)

  • 1. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
    Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.
    Azie N; Neofytos D; Pfaller M; Meier-Kriesche HU; Quan SP; Horn D
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):293-300. PubMed ID: 22789847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Pappas PG; Alexander BD; Andes DR; Hadley S; Kauffman CA; Freifeld A; Anaissie EJ; Brumble LM; Herwaldt L; Ito J; Kontoyiannis DP; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Perl TM; Oster RA; Schuster MG; Walker R; Walsh TJ; Wannemuehler KA; Chiller TM
    Clin Infect Dis; 2010 Apr; 50(8):1101-11. PubMed ID: 20218876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes.
    Zaoutis TE; Webber S; Naftel DC; Chrisant MA; Kaufman B; Pearce FB; Spicer R; Dipchand AI;
    Pediatr Transplant; 2011 Aug; 15(5):465-9. PubMed ID: 21108712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
    Perkhofer S; Lass-Flörl C; Hell M; Russ G; Krause R; Hönigl M; Geltner C; Auberger J; Gastl G; Mitterbauer M; Willinger B; Knöbl P; Resch G; Waldner R; Makrai A; Hartmann G; Girschikofsky M; Greil R
    Int J Antimicrob Agents; 2010 Dec; 36(6):531-6. PubMed ID: 20947312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.
    Lacerda JF; Oliveira CM
    Clin Drug Investig; 2013 Feb; 33 Suppl 1():S5-14. PubMed ID: 23381977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal therapy in invasive fungal infections.
    Chen SC; Playford EG; Sorrell TC
    Curr Opin Pharmacol; 2010 Oct; 10(5):522-30. PubMed ID: 20598943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital.
    Shen YZ; Qi TK; Ma JX; Jiang XY; Wang JR; Xu QN; Huang Q; Liu XN; Sun HQ; Lu HZ
    Mycoses; 2007 Nov; 50(6):475-80. PubMed ID: 17944709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
    Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R
    Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infections in ICU patients: epidemiology and the role of diagnostics.
    Morace G; Borghi E
    Minerva Anestesiol; 2010 Nov; 76(11):950-6. PubMed ID: 21102391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.